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Abstract
Background: Septate uterus, one of the most common forms of congenital uterine malformations, negatively affects 
female reproductive health.
Methods: In a retrospective cohort study, we evaluated the reproductive outcome after hysteroscopic septoplasty in 
64 women with septate uterus and primary or secondary infertility. We performed a systematic review of studies 
evaluating the reproductive outcome after hysteroscopic septoplasty.
Results: Sixty-four women underwent hysteroscopic septoplasty. In 2/64 (3%) women, intraoperative uterine 
perforation occurred. Complete follow-up was available for 49/64 (76%) patients. Mean follow-up time was 68.6 +/- 5.2 
months. The overall pregnancy rate after hysteroscopic septoplasty was 69% (34/49). The overall life birth rate (LBR) was 
49% (24/49). The mean time interval between surgery and the first life birth was 35.8 +/- 22.5 months. Including our 
own data, we identified 18 studies investigating the effect of septoplasty on reproductive outcome in 1501 women. A 
pooled analysis demonstrated that hysteroscopic septoplasty resulted in an overall pregnancy rate of 60% (892/1501) 
and a LBR of 45% (686/1501). The overall rate of intra- and postoperative complications was 1.7% (23/1324) and the 
overall rate of re-hysteroscopy was 6% (79/1324).
Conclusions: In women with septate uterus and a history of infertility, hysteroscopic septoplasty is a safe and effective 
procedure resulting in a pregnancy rate of 60% and a LBR of 45%.
Background
Septate uterus, i.e. an incompletely septated uterus or
uterus subseptus, is one of the most common forms of
congenital uterine malformations [1]. The incidence of
congenital uterine malformations has been reported to be
as high as 3-4% in the general female population [2,3] and
to be significantly higher in patients with infertility and
recurrent pregnancy loss [3,4].
Septate uterus results from incomplete resorption of
the paramesonephric muellerian ducts during the first
trimester of pregnancy. The absorption of the septum
normally initiates at the level of the uterine cervix and
continues upwards in the direction of the uterine fundus.
Depending on the size of the septum, the uterine cavity
may be affected only partially, as in case of an incomplete
septate uterus, or it may be divided into two separate
components including two cervices and eventually a vagi-
nal septum, as in case of a complete septate uterus.
A uterine septum affects female reproductive health in
three ways: (i) obstetric complications, (ii) recurrent mis-
carriages, and (iii) infertility [5]. Although clinical studies
consistently demonstrate a poorer obstetric outcome in
patients with septate uterus compared to women without
uterine anomalies [5,6], literature on septate uterus as the
primary cause of female infertility is controversial. Fedele
et al., for example, were the first to postulate that septate
uterus may influence fertility by hindering embryo
implantation [7]. This hypothesis was based on histologi-
cal samples obtained during operative hysteroscopy dem-
* Correspondence: clemens.tempfer@meduniwien.ac.at
2 Department of Gynecology and Gynecologic Oncology, Medical University of 
Vienna, Vienna, Austria
Full list of author information is available at the end of the articleNouri et al. Reproductive Biology and Endocrinology 2010, 8:52
http://www.rbej.com/content/8/1/52
Page 2 of 8
onstrating the following ultra-structural alterations in the
septal endometrium compared to endometrium of the
lateral uterine wall: (i) a reduced number of glandular
ostia, (ii) irregularly distributed ciliated cells with incom-
plete ciliogenesis, and (iii) a reduction of the ciliated to
non-ciliated cell ratio. These factors are believed to cause
the poor response to estrogens in the septal mucosa,
since normal serum estrogens levels were found in all
patients. Others demonstrated inadequate uterine vascu-
larisation leading to subsequent abnormal placentation in
women with a septate uterus [8]. Moreover, clinical stud-
ies in women with septate uterus reported an increased
content of muscle tissue as well as an increased and unco-
ordinated contractility of the uterine septum [9].
On the other hand, Sparac found no differences in vas-
cularisation assessed by transvaginal colour Doppler
ultrasound comparing endometrium and uterine septum
[9]. In another study, histological examination of uterine
septum biopsies from three different sites of the septum,
namely the basis, the midpoint, and the tip, demonstrated
no differences in terms of muscle tissue and vessel density
compared to biopsies from the left posterior aspect of the
uterus [10].
Available literature on reproductive outcome after uter-
ine septoplasty is inconsistent. For example, pregnancy
rates ranging from 39% [11] to 81% [12] and life birth
rates ranging from 26% [13] to 73% [14] have been
reported. Most of these studies were retrospective. To
our best knowledge, no prospective randomised trial
comparing septoplasty to no intervention has been pub-
lished and is, for ethical reasons, unikely to be conducted
in the future.
The aim of our study was to examine the safety and effi-
cacy of hysteroscopic correction of septate uterus by hys-
teroscopic uterine septoplasty using a retrospective series
of affected women. Furthermore, we conducted a system-
atic review and pooled analysis of studies reporting on
reproductive outcome, complications, and re-operation
rates after this procedure.
Methods
Patients
We retrospectively evaluated all patients having under-
gone hysteroscopic resection of a uterine septum at our
department from 1997 to 2006. Primary outcome param-
eter was obstetric outcome (number of pregnancies,
number of life births). As a second outcome parameter
we evaluated the number and type of intra- and postoper-
ative complications in order to gain information on the
safety of the procedure.
A total of 64 women were enrolled in the study. Four-
teen patients (22%) presented with primary infertility,
defined as the inability to conceive after 12 months of
contraceptive-free intercourse. Fifty patients (78%) pre-
sented with secondary infertility, defined as the inability
to conceive after 12 months of contraceptive-free inter-
course after having already conceived at least once.
Twenty-two of 50 patients with secondary infertility
(44%) have been diagnosed with recurrent abortion,
defined as three or more consecutive spontaneous preg-
nancy losses before 20 weeks gestation. Written informed
consent was obtained from patients for publication of the
data presented. Copies of the written consents are avail-
able for review by the Editor-in-Chief of this journal.
Surgical technique
All operations were performed as in-patient surgery. We
neither used any form of long-term pre-treatment with
danazol or gonadotropin releasing hormone (GnRH) ago-
nists, nor pre-operative intravaginal administration of
misoprostol in contrast to other investigators [15]. Uter-
ine septoplasty was performed under general anaesthesia
by two surgeons combining hysteroscopy and diagnostic
laparoscopy. All procedures were performed in the follic-
ular phase of the menstrual cycle, usually within seven
days after the end of menstruation. In 38 women patency
of the fallopian tubes was tested by chromo-pertubation
with Lipiodol (Lipiodol Ultrafluid Ampul™, Guerbet, Aus-
tria) which was performed after septoplasty.
After cervical dilation with Hegar's dilators up to a
width of 10 mm, an operative hysteroscope (Storz 10 mm
fibreoptic resectoscope; Storz GmbH, Germany) was
inserted. The uterine cavity was distended with a 1.5%
glycine solution with a continuous irrigating flow. The
hysteroscope's hook was placed in contact with the sep-
tum and an incision was made perpendicular to the sep-
tum. All operations were performed with monopolar
electrosurgery, no scissors or lasers were used. The aim of
the procedure was to accomplish a triangular and sym-
metric uterine cavity, which was achieved in all of the
patients Uterine septoplasty was performed under lap-
aroscopic supervision.
Follow up
All patients were sent a questionnaire per mail. The fol-
lowing questions were evaluated: whether the patient
tried to get pregnant after septoplasty; the number of
pregnancies achieved; the number of miscarriages, extra-
uterine pregnancies, and spontaneous abortions, and the
number of life births including information on gestational
week and delivery mode; and whether patients had
undergone any form of assisted reproductive techniques.
All patients were asked to return the completed question-
naire and, in case that they had delivered in another hos-
pital, to enclose a copy of the hospital delivery report or
another document proving the life birth of a child.Nouri et al. Reproductive Biology and Endocrinology 2010, 8:52
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Statistical analysis
Variables are described by frequencies and mean ± stan-
dard deviation (SD) of the mean. Differences between
groups were analyzed by Chi square and Fisher's exact
test. A p-value < 0.05 was considered statistically signifi-
cant. Multiple comparisons were corrected by Bonfer-
roni's correction. Statistical analysis was performed in
SPSS 15.0.1 for Windows (SPSS Inc, 1989-2006).
Systematic literature review
We searched Medline and EMBASE and the Cochrane
controlled trials register (search date: 20.12.2009; search
terms: uterus subseptus, septate uterus, infertility, hyst-
eroscopy, septoplasty) to identify cohort studies, system-
atic reviews, and meta-analyses evaluating the
reproductive outcome after hysteroscopic septoplasty in
women diagnosed with septate uterus. Studies were
included if they were published as complete reports in
English. Bibliographies of studies were searched for rele-
vant citations. Multiple studies describing the same study
population were included once. In this case, the original
publication was used, i.e. the one with the earliest date of
publication. Two authors assessed the eligibility of the
studies and extracted data (KN and JO). Missing informa-
tion and additional trials were not sought from authors.
Data on pregnancy, life birth rates, complications, and re-
hysteroscopy rates were extracted, pooled, and re-ana-
lyzed.
Results
Surgical procedure
Fifty-seven of 64 patients (89%) underwent uterine septo-
plasty as described above including diagnostic laparos-
copy and operative hysteroscopy. The mean age of the
patients was 30.3 ± 5.7 years, the mean body mass index
was 23.9 ± 2.7, and the mean duration of infertility was
4.5 ± 2.7 years. In 4/64 patients (6%) only operative hyst-
eroscopy for dissection of the uterine septum was per-
formed, whereas 3 patients (4%) underwent an additional
curettage. Sixty-two patients had uneventful intraopera-
tive and postoperative courses. However, in 2/64 (3%)
patients, uterine perforation occurred. In both cases no
adjacent organs were injured and the complication was
managed by bipolar coagulation. No sutures were
applied. No postoperative episode of fever was noted.
Re-septoplasty
In 8/64 (13%) patients a second intervention was neces-
sary since the uterine septum had not been completely
removed during the first operation. The re-operation was
done after a mean of 14.4 ± 10.7 months. Re-septoplasty
was more often necessary in patients who had undergone
hysteroscopy only than in those who had undergone
combined hysteroscopy and laparoscopy (2/4 [50% vs. 6/
45 [11%]; p = 0.07).
Obstetric outcome
Complete follow-up was available for 49/64 (77%)
patients. Mean follow-up time was 68.6 ± 25.2 months.
All of the patients tried to become pregnant after septo-
plasty. The overall pregnancy rate after septoplasty was
6 9 %  ( 3 4 / 4 9 ) .  E l e v e n  p a t i e n t s  r e p o r t e d  m o r e  t h a n  o n e
pregnancy. Specifically, six women had two pregnancies,
two women had three pregnancies, two women had four
pregnancies, and one woman had six pregnancies,
respectively. Thus, we registered a total of 49 pregnan-
cies. Sixteen pregnancies had resulted from in vitro fertil-
ization (33%), three pregnancies from insemination (6%),
and the remaining 27 pregnancies (55%) resulted from
spontaneous conception.
The overall life birth rate (LBR) was 49% (24/49). All life
births were confirmed by hospital birth records. Three
patients reported two life births, one patient reported
three life births. Table 1 shows the reproductive outcome
of women with and without a history of early spontane-
ous miscarriages and women with and without a history
of recurrent miscarriages, ie three or more miscarriages.
Women with a history of recurrent miscarriages had a
significantly higher pregnancy rate after uterine septo-
plasty compared to women without a history of recurrent
miscarriages.
The mean time interval between uterine septoplasty
and the first delivery was 35.8 ± 22.5 months. Out of a
total of 29 life births, 9 (31%) were preterm deliveries
before 37 weeks gestation. No difference regarding pre-
term deliveries was observed comparing patients with or
without a history of recurrent miscarriages (6/21 [29%]
vs. 3/8 [38%], respectively; p = 0.6).
Figure 1 shows a graph of the time to first life birth in
women after uterine septoplasty, demonstrating a slow,
but consistent increase of life births during the observa-
tion period of 80 months. Cesarean section was the deliv-
ery mode in 12/29 (41%) women. The remaining 17
babies were delivered vaginally (59%). None of the
patients was diagnosed with uterine rupture in the course
of pregnancy and delivery.
Cofactors of infertility
Complete information on hormonal status, patency rates
of the fallopian tubes, and the result of the partner's
semen analysis was available for 21/64 (33%) women.
Male factor, unilateral tubal factor, bilateral tubal factor,
and hormonal pathologies, ie hyperprolactinemia, hyper-
androgenemia, and thyroid dysfunction were noted in 14,
9, 3, and 11 of these women, respectively. Women with a
bilateral tubal factor underwent in vitro fertilization. In 8/
49 (16%) women, a change of the male partner was noted.Nouri et al. Reproductive Biology and Endocrinology 2010, 8:52
http://www.rbej.com/content/8/1/52
Page 4 of 8
Systematic review and meta-analysis
We identified 18 studies investigating the outcomes after
hysteroscopic uterine septoplasty [11-28]. One study was
excluded from the analysis of obstetric outcomes,
because data on pregnancy rates and LBR could not be
extracted [17]. Table 2 provides an overview of the indi-
vidual studies including our own data and a pooled analy-
sis of 1501 women, yielding an overall pregnancy rate of
60.1% (892/1501) and a LBR of 45.0% (686/1501) after
uterine septoplasty.
Details on postoperative complications and re-hyst-
eroscopy rates are given in Table 3. For this analysis we
excluded four studies [11,12,16,18] with a total of 242
patients because the complication rates were not given in
these studies. The pooled analysis of 14 studies with 1324
women undergoing uterine septoplasty resulted in an
overall complication rate of 1.7% (23/1324). The overall
rate of re-hysteroscopy was 6.0% (79/1324). There was no
statistically significant difference regarding overall PR,
LBR, and complications comparing our series with the
Table 1: Obstetric outcome after hysteroscopic septoplasty of women with and without a history of early miscarriage and 
of women with and without a history of recurrent miscarriage
Patients with a history of 
early miscarriage (n = 47)
Patients without a history of 
early miscarriage (n = 17)
p-value
Follow-up time (months) 66.1 ± 25.6 72.6 ± 24.3 0.1
Pregnancy rate 25/37 (68%) 9/12 (75%) 0.6
Life birth rate 18/37 (49%) 6/12 (50%) 0.9
Miscarriage rate 7/37 (19%) 3/12 (25%) 0.7
Patients with a history of 
recurrent miscarriage (n = 22)
Patients without a history of 
recurrent miscarriage (n = 42)
p-value
Follow-up time (months) 62.2 ± 23.8 69.4 ± 24.7 0.09
Pregnancy rate 16/17 (94%) 18/32 (56%) 0.04*
Life birth rate 11/17 (64%) 13/32 (40%) 0.1
Miscarriage rate 5/17 (29%) 5/32 (16%) 0.3
*after Bonferroni's correction
Figure 1 Cumulative life birth rate after uterine septoplasty.
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pooled data from 17 studies in the literature (data not
shown).
Discussion
In this retrospective cohort study of 64 women and a
pooled analysis of 18 studies including 1501 women, we
describe a pregnancy rate of 60% and a LBR of 45% after
hysteroscopic septoplasty in women with septate uterus.
We conclude that hysteroscopic septoplasty is a simple,
effective, and safe procedure with an intra- and postoper-
ative complication rate of 1.7%. Our data, therefore, sup-
port the use of this procedure and confirm a high rate of
reproductive success in women with a septate uterus.
Septate uterus used to be treated by transabdominal
metroplasty [29]. This surgical method has been substi-
tuted by operative hysteroscopy. The reasons were a high
complication rate of abdominal metroplasty including the
risk of postoperative adhesions potentially leading to
infertility. Also, abdominal metroplasty was associated
with an increased risk of scar rupture during pregnancy,
resulting in the recommendation of cesarean section as
the preferred mode of delivery [29]. Furthermore, laparo-
tomy is associated with longer hospital stays compared to
operative hysteroscopy.
The only advantage of performing a laparotomy in
women with septate uterus is the possibility to evaluate
and diagnose associated pelvic pathologies and to assess
Table 2: Literature on pregnancy rates and live birth rates after hysteroscopic uterine septoplasty in women with septate 
uterus
Author Year Patient 
number
Uterine 
mal-
formation
Patient 
characteristics
Pregnancy 
rate
Live birth rate
Venturoli et al. [13] 2002 141 IUS Infertility; RM 74/141 (52%) 56/141 (39%);
14 ongoing
Doridot et al [14] 2003 70 CUS 21 PI; 33 RM; 16 LM 
or PT
8/21 (38%); 
13/33 (38%); 
10/16 (60%)
-
Jakiel et al. [15] 2004 31 CUS PI; RM; LM and PT 18/31 (58%) 11 (38%)
Hollett-Caines et al. [20] 2006 26 CUS Infertility; RM 21/26 (80%) 15/26 (57%)
Pace et al. [16] 2006 70 IUS; CUS PI; RM; PT 30/40 (75%) 25/40 (62%)
Colacurci et al. [21] 2007 135 CUS Infertility 99/135 (73%) 82/135 (60%)
Colacurci et al. [22] 1996 69 IUS; CUS PI; RM 46/69 (66%) 36/69 (52%);
4 ongoing
Saygili-Yimaz et al. [23] 2003 361 CUS PI; RM 180/361 (49%) 124/361 (34%)
Pabuçcu & Gomel [24] 2004 61 CUS PI 25/61 (41%) 18/61 (29%)
Valle RF [26] 1996 124 CUS RM 101/124 (81%) 91/124 (73%)
Ozgur et al. [11] 2007 119 IUS IVF 57/119 (47%) 51/119 (42%)
Marabini et al. [27] 1994 40 CUS Infertility; RM 19/26 (73%) 13/26 (50%);
4 ongoing
Kupesic & Kurjak [28] 1998 116 CUS Infertility 59/116 (50%) 48/116 (41%)
Porcu et al. [29] 2000 63 CUS RM 45/56 (80%) 28/56 (50%)
Guarino et al. [31] 1989 35 CUS PI; RM 18/35 (51%) 16/35 (45%)
Wang et al. [30] 2008 25 CUS PI and SI; RM 13/23 (56%) 6/23 (26%);
6 ongoing
Mollo et al. [17] 2009 44 CUS - 17/44 (38%) 15/44(34%)
Litta et al. [25] 2007 63 IUS - 36/45 (80%) 27/45 (60%)
Nouri et al. 2010 64 IUS PI and SI; RM 34/49 (69%) 24/49 (49%)
Total - 1587 IUS; CUS - 892/1501 
(60%)
686/1501 
(45%)
IUS = incomplete uterine septum; CUS = complete uterine septum; RM = recurrent miscarriages; PT = preterm delivery; PI = primary infertility; 
SI = secondary infertility; LM = late miscarriagesNouri et al. Reproductive Biology and Endocrinology 2010, 8:52
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Table 3: Literature on complications during and after hysteroscopic uterine septoplasty in women with septate uterus
Ref Year N LSK POT UM Complications
PP F P P C L R P
[13] 2002 141 - - IUS - - - - -
[14] 2003 70 Yes - CUS 2 0 0 0 2
[15] 2004 31 - - CUS - - - - -
[20] 2006 26 - - CUS - - - - -
[16] 2006 70 Yes GnRH
D
IUS; 
CUS
00000
[21] 2007 135 - - CUS 0 0 0 0 0
[22] 1996 69 No GnRH IUS; 
CUS
00002
[23] 2003 361 No D CUS 10 0 0 0 49
[24] 2004 61 No - CUS 0 0 0 0 14
[26] 1996 124 No Yes CUS 0 0 0 0 4
[11] 2007 119 No M CUS 0 0 0 0 0
[28] 1994 40 No D;
PGE1
C U S 00001
[29] 1998 116 No - CUS 0 0 0 0 0
[30] 2000 63 - - CUS 1 0 0 0 1
[31] 1989 35 No - CUS 0 0 0 0 0
[30] 2008 25 No - CUS 0 0 0 0 0
[17] 2009 44 - - CUS - - - - -
[25] 2007 63 No - IUS 0 0 1 2 4
PS 2010 64 Yes - IUS 2 0 0 0 2
PA - 1324 204
15.4%
-I U S ;  
CUS
15
1.1%
01
0.07%
2
0.1%
79
6.0%
Ref = reference; n = number of patients; Year = year of publication; UM = uterine malformation; P = perforation; PF = postoperative fever; LSK 
= concomitant laparoscopy; PP = pelvic pain; CL = cervical laceration; RP = re-operation; POT = pre-operative therapy; IUS = incomplete 
uterine septum; CUS = complete uterine septum; GnRH = gonadotropin releasing hormone agonist; D = danazol; FOS = fluid overload 
syndrome; M = misoprostol in 2 patients 2 hours prior to surgery; PGE1 = prostaglandin E1; IU = intrauterine adhesions; PS = present study 
(Nouri et al. 2010); PA = pooled analysisNouri et al. Reproductive Biology and Endocrinology 2010, 8:52
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tubal patency [30]. However, this can easily be achieved
by concomitant hysteroscopy and laparoscopy. For exam-
ple, in our series, 12/57 women were found to have a uni-
or bilateral tubal factor. In addition, concomitant laparos-
copy helped us to control the septum dissection from
outside the uterus, diagnose and manage uterine perfora-
tion, if it occurred, and to potentially minimize the risk of
such a complication. On the other hand, however, most
series included in this review did not use concomitant
laparoscopy with no apparent disadvantage regarding
safety and efficacy of the procedure.
We used a resectoscope for septoplasty in our series. In
the investigated studies, several different methods and
instruments for hysteroscopic septoplasty have been
described, namely scissors, resectoscope, and argon laser.
Data on the impact of the hysteroscopic technique on the
reproductive outcome, however, are rare. Cararach et al.
compared the reproductive outcome of patients operated
by resectoscope with those in whom scissors have been
used. They found a higher pregnancy rate in the scissors
group [31]. On the other hand, Fedele et al. could not find
a difference comparing the reproductive outcome results
obtained with microscissors, argon laser, and resecto-
scope, in their series [7]. Thus, it is unclear, whether the
use of a specific instrument may improve outcome and
further comparative trials should be encouraged. Opera-
tive hysteroscopy may be performed using monopolar or
bipolar electrosurgery. Bipolar electrosurgery uses iso-
tonic saline as distension medium and may be safer and
more effective for hysteroscopic surgery compared to
monopolar electrosurgery based on one randomized trial
[32]. A definitive recommendation, however, is prema-
ture at this time.
The insertion of intrauterine device (IUD) has been
proposed as an option to potentially prevent both post-
operative pregnancy and the development of intrauterine
adhesions [30]. This practice, however, is not recom-
mended and it's efficacy is unknown. In our series, we did
not use an IUD system and advised the patients to use a
safe contraceptive method for three months after surgery.
Re-operations were rarely necessary in our series and in
the pooled analysis of all 18 trials with re-operation rates
of 3% and 6%, respectively. This indicates that hystero-
scopic uterine septoplasty can achieve effective removal
of the septum in most cases. Adequate distension of the
uterine cavity and loss of distension fluid through the cer-
vix may influence the efficacy of septum removal and
thus influence re-septoplasty rates. The influence of these
factors, however, has not been investigated in the present
study. Given that most series were published by public
institutions with residency programs, these data also
indicate that hysteroscopic uterine septoplasty may be
considered an operation with a steep learning curve. This
is consistent with our experience that this operation is
easy to teach and easy to learn, especially with concomi-
tant laparoscopy.
Another point of interest is whether or not a pre-opera-
tive therapy should be recommended prior to hystero-
scopic uterine septoplasty. Preparation of the
endometrium with various agents, including GnRH ana-
logues, danazol, misoprostol, and PGE1 tablets, was used
in 6/18 studies. This demonstrates that most surgeons do
not find it necessary to use any form of pre-operative
therapy. Furthermore, a recent randomized trial could
not detect a benefit of 200 μg of sublingual misoprostol in
women undergoing diagnostic hysteroscopy [33]. Also,
the heterogeneity of the medications used does not allow
to recommend a specific therapy.
It is of note that women undergoing hysteroscopic sep-
toplasty are also at risk of uterine rupture in a subsequent
pregnancy. Sentilhes et al. describe a total of 14 cases of
uterine rupture after operative hysteroscopy in the litera-
ture [34]. Of these, 12 had a history of septoplasty.
Although obviously a rare complication, patients should
be made aware of this potentially serious late complica-
tion of hysteroscopic septoplasty.
Conclusions
In summary, we describe a retrospective cohort study and
a pooled analysis of 18 studies on the safety and efficacy
of hysteroscopic uterine septoplasty in women with sep-
tate uterus. We found that this procedure is safe and
effective with a subsequent pregnancy rate of 69% and a
LBR of 49%.
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